Pathologic lymph node status is the most important prognostic factor in vulvar cancer; however, complete inguinofemoral node dissection is associated with significant morbidity. Intraoperative lymphoscintigraphy associated with gamma detecting probe-guided surgery has proved to be reliable in the detection of sentinel node (SN) involvement in melanoma and breast cancer patients. The present study evaluates the feasibility of the surgical identification of inguinal sentinel nodes using lymphoscintigraphy and a gamma detecting probe in patients with early vulvar cancer.
Methods
Technetium-99-labeled colloid human albumin was administered perilesionally in 44 patients. Twenty patients had T1 and 23 had T2 invasive epidermoid vulvar cancer; one patient had a lower-third vaginal cancer. An intraoperative gamma detecting probe was used to identify SNs during surgery. Complete inguinofemoral node dissection was subsequently performed. SNs underwent separate pathologic evaluation.
Results
A total of 77 groins were dissected in 44 patients. SNs were identified in all the studied groins. Thirteen cases had positive nodes: the SN was positive in all of them; in 10 cases the SN was the only positive node. Thirty-one patients showed negative SNs: all of them were negative for lymph node metastasis.
Conclusions
Lymphoscintigraphy and SN biopsy under gamma detecting probe guidance proved to be an easy and reliable method for detection of SNs in early vulvar cancer. If these preliminary data will be confirmed, the technique would represent a real progress towards less aggressive treatment in patients with vulvar cancer.
AndrewsS.J., WilliamsB.T., DePriestP.D., GallionH.H., HunterJ.E., BuckleyS.L., KryscioR.J., van NagellJ.R.: Therapeutic implications of lymph nodal spread in lateral Tl and T2 squamous cell carcinoma of the vulva.Gynecol. Oncol., 55: 41–46, 1994.
4.
AsinkA.C., DaisyM.D.S., van der VeldenJ., SijmonsE., LopesA.B., MonaghanJ.M.M., KenterG.G., MurdochJ.B., ten KateF.J.W., HeintzA.P.M.: Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection.A multicenter study. Cancer, 86: 652–656, 1999.
5.
BartonD.P.J., BermanC., CavanaghD., RobertsW.S., HoffmanM.S., FioricaJ.V., FinanM.A.: Lymphoscintigraphy in vulvar cancer: a pilot study.Gynecol. Oncol., 46: 341–344, 1992.
6.
BermanM.L., SoperJ.T., CreasmanW.T., OltG.T., Di SaiaP.J.: Conservative surgical management of superficially invasive vulvar carcinoma.Gynecol. Oncol., 35: 352–357, 1989.
7.
BinderS.W., HuangI., FuY.S., HackerN.F., BerekJ.S.: Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma.Gynecol. Oncol., 37: 9–16, 1990.
8.
BurgerM.P.M., HollemaH., EmanuelsA.G., KransM., PrasE., BoumaJ.: The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.Gynecol. Oncol., 57: 327–334, 1995.
9.
BurkeT.W., StringerC.A., GershensonD.M., CreightonL.E., MorrisM., Taylor WarthonJ.: Radical wide excision and selective node dissection for squamous cell carcinoma of the vulva.Gynecol. Oncol., 38: 328–332, 1990.
10.
BurkeT.W., LevenbackC., ColemanR.L., MorrisM., SilvaE.G., GershensonD.M.: Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy.Gynecol. Oncol., 57: 215–220, 1995.
11.
De CesareS.L., FioricaJ.V., RobertsW.S., ReintgenD., ArangoH., HoffmanM.S., PulloC., CavanaghD.: A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel nodes in vulvar cancer.Gynecol. Oncol., 66: 425–428, 1997.
12.
De HulluJ.A., DotingE., PiersD.A., HollemH., AaldersJ.G., Schraffords KoopsH., BoonstraH., van der ZeeA.G.J.: Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva.J. Nucl. Med., 39: 1381–1385, 1998.
13.
Di SaiaP.J., CreasmanW.T., RichW.M.: An alternate approach to early cancer of the vulva.Am. J. Obstet. Gynecol., 133: 825–830, 1979.
14.
FlannellyG.M., FoleyM.E., LenehanP.M., KelehanP., MurphyJ.F., StrongeJ.: En bloc radical vulvectomy and lymphadenectomy with modifications of separate groin incisions.Obstet. & Gynecol., 79: 307–309, 1992.
15.
GiulianoA.E., KirganD.M., GuentherJ.M., MortonD.L., EvansS.W., KrasneD.L.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann. Surg., 220: 391–401, 1994.
16.
GiulianoA.E., DaleP.S., TurnerR.R., MortonD.L., EvansS.W., KrasneD.L.: Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann. Surg., 222: 394–401, 1995.
17.
ICRP International Commission on Radiological Protection. Publication 60. Pergamon Press, Oxford, 1991.
18.
IversenT., AasM.: Lymph drainage from the vulva.Gynecol. Oncol., 16: 179–189, 1983.
19.
KragD.N., WeaverD.L., AlexJ.C., FairbankJ.T.: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg. Oncol., 2: 335–340, 1993.
LevenbackC., BurkeT.W., MorrisM., MalpicaA., LucasK.R., GershensonD.M.: Potential applications of intraoperative lymphatic mapping in vulvar cancer.Gynecol. Oncol.,59: 216–220, 1995.
22.
MichelettiL., BorgnoG., BarberoM., PretiM., CavannaL., NicolaciP., BenedettoC., GhiringhelloB., BocciA.: Deep femoral lymphadenectomy with preservation of the fascia lata.Preliminary report on 42 invasive vulvar carcinomas. J. Reprod. Med., 35: 1130–1133, 1990.
23.
MortonD., WenD., WongJ.H., EconomouJ.S., CagleL.A., StormF.K., FoshagL.T., CochranA.: Management of earlystage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or “watch and wait”.Surg. Oncol. Clin. North. Am., 1: 247–259, 1992.
24.
MortonD., WenD., WongJ., EconomouJ.S., CagleL.A., StormF.K., FoshagL.J., CochranA.J.: Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch. Surg., 127: 392–399, 1992.
25.
OrigoniM., SideriM., GarsiaS., CarinelliS.G., FerrariA.: Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage II and Iva FIGO.Gynecol. Oncol., 45: 313–316, 1992.
26.
PaladiniD., CrossP., LopesA., MonaghanJ.M.: Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva.Cancer,74, 2491–2496, 1994.
27.
PodratzK.C., SymmondsRE., TaylorF.: Carcinoma of the vulva: analysis of treatment failures.Am. J. Obstet. Gynecol.,143, 340–351, 1982.
28.
SillerB.S., AlvarezR.D., ConnerW.D., McCulloghC.H., KilgoreL.C., PartridgeE.E., AustinJ.M.: T2/3 vulva cancer: a case control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy.Gynecol. Oncol., 57: 335–339, 1995.
29.
StehmanF.B., BundyB.N., DvoretskyP.M., CreasmanW.T.: Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectmy: a prospective study of the Gynecologic Oncology Group.Obstet. Gynecol., 79: 490–497, 1992.
30.
StehmanF.B., BundyB.N., BallH., Clarke PearsonD.L.: Sites of failure and time to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study.Am. J. Obstet. Gynecol., 174: 1128–1132, 1996.
31.
SuttonG.P., MiserM.R., StehmanF.B., LookK.Y., EhrlichC.E.: Trends in operative management of invasive squamous carcinoma of the vulva at Indiana University, 1974 to 1988.Am. J. Obstet. Gynecol., 164: 1472–1481, 1991.
32.
ThomasG.M., DemboA.J., BrysonS.C.P., OsborneR., De PetrilloA.D.: Changing concepts in the management of vulvar cancer.A review. Gynecol. Oncol., 42: 9–21, 1991.
33.
Van der VeenH., HoekstraO.S., PaulM.A., CuestaN.A., MeijerS.: Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy.Br. J. Surg., 81: 1769–1770, 1996.
34.
Van der VeldenJ., Van LindertA.C., LammesF.B., ten KateF.J., Sie GoD.M., OostingH., HeintzA.P.: Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival.Cancer, 75: 2885–2890, 1995.
35.
VeronesiU., PaganelliG., GalimbertiV., VialeG., ZurridaS., BedoniM., CostaA., De CiccoC., GeraghtyJ.G., LuiniA., SacchiniV., VeronesiP.: Sentinel node biopsy can avoid axillary dissection in breast cancer patients with clinically negative lymph nodes.Lancet, 349: 1864–1867, 1997.
